G - Physics – 01 – N
Patent
G - Physics
01
N
G01N 33/68 (2006.01) C12Q 1/68 (2006.01) G01N 33/53 (2006.01)
Patent
CA 2709621
Use of clusterin as a biomarker of Alzheimer's disease (AD), particularly methods and compositions for detection of clusterin in a biological sample and assessment of in vivo pathology, disease severity and rate of clinical progression in a subject having or suspected of having AD.
Campbell James
Lovestone Simon
Thambisetty Madhav
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Electrophoretics Limited
King's College London
LandOfFree
Markers and methods relating to the assessment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Markers and methods relating to the assessment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Markers and methods relating to the assessment of... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1811647